within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AJ03_Dolutegravir;

model Dolutegravir
  extends Pharmacolibrary.Drugs.ATC.J.J05AJ03;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AJ03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Dolutegravir is an antiretroviral medication used in the treatment and prevention of HIV/AIDS. It is an integrase strand transfer inhibitor (INSTI) that blocks the HIV integrase enzyme and thereby prevents viral replication. Dolutegravir is approved for use in combination with other antiretroviral agents and is widely used as part of first-line HIV therapy due to its high efficacy, favorable safety profile, and resistance barrier.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters from healthy adult subjects following oral administration of 50 mg dolutegravir once daily.</p><h4>References</h4><ol><li><p>Singh, RP, et al., &amp; Wynne, B (2021). Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants. <i>Clinical pharmacology in drug development</i> 10(9) 985–993. DOI:<a href=\"https://doi.org/10.1002/cpdd.996\">10.1002/cpdd.996</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34265164/\">https://pubmed.ncbi.nlm.nih.gov/34265164</a></p></li><li><p>Scarsi, KK, et al., &amp; Fletcher, CV (2020). HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety. <i>Drugs</i> 80(16) 1649–1676. DOI:<a href=\"https://doi.org/10.1007/s40265-020-01379-9\">10.1007/s40265-020-01379-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32860583/\">https://pubmed.ncbi.nlm.nih.gov/32860583</a></p></li><li><p>Song, IH, et al., &amp; Piscitelli, SC (2015). Dolutegravir Has No Effect on the Pharmacokinetics of Oral Contraceptives With Norgestimate and Ethinyl Estradiol. <i>The Annals of pharmacotherapy</i> 49(7) 784–789. DOI:<a href=\"https://doi.org/10.1177/1060028015580637\">10.1177/1060028015580637</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25862012/\">https://pubmed.ncbi.nlm.nih.gov/25862012</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Dolutegravir;
